THIRD AMENDMENT TO THE DEVELOPMENT AND SUPPLY AGREEMENTDevelopment and Supply Agreement • January 23rd, 2023 • HH&L Acquisition Co. • Services-medical laboratories
This Third Amendment to Development and Supply Agreement (“Third Amendment”), effective as of September 26, 2022 (the “Third Amendment Effective Date”), is entered into between Luminex Corporation, a Delaware corporation with principal offices at 12212 Technology Boulevard, Austin, Texas 78727 (“Luminex”), and DiaCarta Inc., a California corporation, with principal offices at 4385 Hopyard Road, Suite 100, Pleasanton, CA, 94588 (“DiaCarta”). Luminex and DiaCarta are each referred to herein individually as a “Party” and collectively as the “Parties”.
DEVELOPMENT AND SUPPLY AGREEMENT (for Assay Products and Testing Services)Development and Supply Agreement • January 23rd, 2023 • HH&L Acquisition Co. • Services-medical laboratories • Texas
This Development and Supply Agreement (the “Agreement”), effective as of June 30, 2018 (the “Effective Date”), is entered into by and between Luminex Corporation, a Delaware corporation with principal offices at 12212 Technology Boulevard, Austin, Texas 78727 (“Luminex”), and DiaCarta Inc., a California company located at 2600 Hilltop Rd., Richmond, California 94806 (“DiaCarta”).
